Supporting Family Adaptation to Presymptomatic and Untreatable Conditions in an Era of Expanded Newborn Screening

被引:26
|
作者
Bailey, Donald B., Jr.
Armstrong, F. Daniel [1 ]
Kemper, Alex R. [2 ]
Skinner, Debra [3 ]
Warren, Steven F. [4 ]
机构
[1] Miller Sch Med, Miami, FL USA
[2] Duke Univ, Program Pediat Hlth Serv Res, Durham, NC 27706 USA
[3] Univ N Carolina, Inst Child Dev, FPG, Chapel Hill, NC USA
[4] Univ Kansas, Schiefelbush Inst Lifespan Studies, Lawrence, KS 66045 USA
关键词
early identification; family support; newborn screening; SICKLE-CELL-DISEASE; FRAGILE-X-SYNDROME; YOUNG-CHILDREN; FOLLOW-UP; DEVELOPMENTAL DELAYS; EARLY INTERVENTION; HEALTH-CARE; PARENTS; GENETICS; COMMUNICATION;
D O I
10.1093/jpepsy/jsn032
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective As technology advances, newborn screening will be possible for conditions not screened today. With an expansion of screening, strategies will be needed to support family adaptation to unexpected and possibly uncertain genetic information provided shortly after birth. Method Although candidate conditions for expanded newborn screening will typically be associated with increased morbidity or mortality, for most there is no proven medical treatment that must be implemented quickly. Many will have clinical features that gradually emerge and for which the severity of impact is not predictable. Parents will seek guidance on information, support, and treatment possibilities. This article summarizes issues evoked by expanded newborn screening and suggests strategies for supporting families of identified children. Results We propose four components necessary to support family adaptation to pre-symptomatic and untreatable conditions in an era of expanded newborn screening: (1) accurate and understandable information; (2) formal and informal support; (3) active surveillance; and (4) general and targeted interventions. We argue that no condition is untreatable and that a well-designed program of prevention and support has the potential to maximize benefit and minimize harm. Conclusions Pediatric psychologists can play important roles in an era of expanded newborn screening by helping families understand genetic information, make informed decisions about genetic testing, and cope with the potential psychosocial consequences of genetic information.
引用
收藏
页码:648 / 661
页数:14
相关论文
共 14 条
  • [1] Expanded Newborn Screening: Information and Resources for the Family Physician
    Weismiller, David Glenn
    AMERICAN FAMILY PHYSICIAN, 2017, 95 (11) : 703 - 709
  • [2] Expanded newborn screening: Information and resources for the family physician
    Waisbren, Susan E.
    AMERICAN FAMILY PHYSICIAN, 2008, 77 (07) : 987 - 994
  • [3] Expanded Newborn Screening Using Genome Sequencing for Early Actionable Conditions
    Ziegler, Alban
    Koval-Burt, Carrie
    Kay, Denise M.
    Suchy, Sharon F.
    Begtrup, Amber
    Langley, Katherine G.
    Hernan, Rebecca
    Amendola, Laura M.
    Boyd, Brenna M.
    Bradley, Jennifer
    Brandt, Tracy
    Cohen, Lilian L.
    Coffey, Alison J.
    Devaney, Joseph M.
    Dygulska, Beata
    Friedman, Bethany
    Fuleihan, Ramsay L.
    Gyimah, Awura
    Hahn, Sihoun
    Hofherr, Sean
    Hruska, Kathleen S.
    Hu, Zhanzhi
    Jeanne, Mederic
    Jin, Guanjun
    Johnson, D. Aaron
    Kavus, Haluk
    Leibel, Rudolph L.
    Lobritto, Steven J.
    Mcgee, Stephen
    Milner, Joshua D.
    Mcwalter, Kirsty
    Monaghan, Kristin G.
    Orange, Jordan S.
    Soler, Nicole Pimentel
    Quevedo, Yeyson
    Ratner, Samantha
    Retterer, Kyle
    Shah, Ankur
    Shapiro, Natasha
    Sicko, Robert J.
    Silver, Eric S.
    Strom, Samuel
    Torene, Rebecca I.
    Williams, Olatundun
    Ustach, Vincent D.
    Wynn, Julia
    Taft, Ryan J.
    Kruszka, Paul
    Caggana, Michele
    Chung, Wendy K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (03): : 232 - 240
  • [4] Follow-up of fatty acid -oxidation disorders in expanded newborn screening era
    Janeiro, Patricia
    Jotta, Rita
    Ramos, Ruben
    Florindo, Cristina
    Ventura, Fatima V.
    Vilarinho, Laura
    de Almeida, Isabel Tavares
    Gaspar, Ana
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (03) : 387 - 394
  • [5] Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era
    Patrícia Janeiro
    Rita Jotta
    Ruben Ramos
    Cristina Florindo
    Fátima V. Ventura
    Laura Vilarinho
    Isabel Tavares de Almeida
    Ana Gaspar
    European Journal of Pediatrics, 2019, 178 : 387 - 394
  • [6] Expanded Prenatal Genetic and Newborn Screening: One Family's Wild Ride
    Anderson, Sharon
    Botti, Christina
    JOURNAL OF PEDIATRIC HEALTH CARE, 2019, 33 (05) : 568 - 577
  • [7] UPDATE OF EXPANDED NEWBORN SCREENING (NBS) IN WASHINGTON STATE ON UNIQUE PANEL OF 28 CONDITIONS
    Blake, A.
    Glass, M.
    Thompson, J.
    Weiss, S.
    Hale, S.
    Sniderman-King, L.
    Raff, M.
    Hahn, S.
    Scott, C. R.
    Merritt, J. L., II
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 112 - 113
  • [8] Expanded newborn screening and the emerging genomic era - Preliminary lessons from 13-year experience
    Landau, Yuval E.
    Waisbren, Susan
    Levy, Harvey L.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 332 - 332
  • [9] Diagnostic Utility of Cord Blood Thyroid Stimulating Hormone in Congenital Hypothyroidism in the Era of Expanded Newborn Screening
    Nasheeda C.M.
    Philip P.
    Shenoy R.D.
    Shetty S.
    Indian Journal of Clinical Biochemistry, 2018, 33 (4) : 461 - 466
  • [10] Expanded newborn screening(NBS) leads to early diagnosis and treatment in children with Cobalamin C disease (Cb1C) and aids in identifying and treating presymptomatic affected family members
    Herman, Isabella
    Handoko, Maureen
    Emrick, Lisa
    NEUROLOGY, 2019, 92 (15)